SCOPUS 정보 검색 플랫폼

EDTNA-ERCA Journal

Volumn 29, Issue 3, 2003, Pages 112-117

Citrate anticoagulation and adverse events

(2) De Vos, J a,b Hombrouckx, R a,b

a Dialysis Unit (Belgium)

b AZ Werken Glorieux (Belgium)

Author keywords

Alkalosis; Aluminium; Citrate; Heparin intolerance; Hypernatraemia

Indexed keywords

CITRIC ACID; HEPARIN;

ALKALOSIS; ALUMINUM BLOOD LEVEL; BICARBONATE BLOOD LEVEL; BLOOD FLOW; CLINICAL TRIAL; DIALYSIS; DRUG HYPERSENSITIVITY; HUMAN; HYPERNATREMIA; REVIEW; THROMBOCYTOPENIA;

EID: 0042193497 PISSN: 1019083X EISSN: None Source Type: Journal
DOI: 10.1111/j.1755-6686.2003.tb00289.x Document Type: Review

Times cited : (13)

References (9)

1
- 0025089550
- Regional citrate anticoagulation for continuous arterio venous haemodialysis in critically ill patients
- Ravindra LM. et al. Regional citrate anticoagulation for continuous arterio venous haemodialysis in critically ill patients. Kidney International 1990; (38): 976-981.
- (1990) Kidney International , Issue.38 , pp. 976-981
- Ravindra, L.M.¹

2
- 0022979273
- Regional anticoagulation: Haemodialysis with hypertonic tri-sodium citrate
- Von Brecht JH. et al. Regional Anticoagulation: Haemodialysis With Hypertonic Tri-sodium Citrate. American Journal of Kidney Diseases 1986; Vol VIII (3) 196-201.
- (1986) American Journal of Kidney Diseases , vol.8 , Issue.3 , pp. 196-201
- Von Brecht, J.H.¹

3
- 0023094752
- Reducing the hemorrhagic complications of haemodialysis: A controlled comparison of low-dose heparin and citrate anticoagulation
- Flanigan MJ. et al. Reducing the Hemorrhagic Complications of Haemodialysis: A Controlled Comparison of Low-Dose Heparin and Citrate Anticoagulation. American Journal of Kidney Diseases 1987; Vol IX (2) 147-153.
- (1987) American Journal of Kidney Diseases , vol.9 , Issue.2 , pp. 147-153
- Flanigan, M.J.¹

4
- 0027386105
- Citrate versus heparin anticoagulation in chronic haemodialysis patients
- Janssen M. et al. Citrate versus heparin anticoagulation in chronic haemodialysis patients. Nephrology Dialysis Transplantation 1993; 8: 1228-1233.
- (1993) Nephrology Dialysis Transplantation , vol.8 , pp. 1228-1233
- Janssen, M.¹

5
- 0029972550
- Regional haemodialysis anticoagulation: Hypertonic trisodium citrate or anticoagulant citrate dextrose
- Flanigan MJ. et al. Regional haemodialysis anticoagulation: Hypertonic trisodium citrate or anticoagulant citrate dextrose. American Journal Kidney Diseases 1996; 27 (4): 519-524.
- (1996) American Journal Kidney Diseases , vol.27 , Issue.4 , pp. 519-524
- Flanigan, M.J.¹

6
- 0026472418
- Precipitations and characterization of an Aluminosilicate form Al Cl3 - Na2SiO3 - HCl in serum, of interest for Alzheimer disease
- Biliniski H et al. Precipitations and characterization of an Aluminosilicate form Al Cl3 - Na2SiO3 - HCl in serum, of interest for Alzheimer disease. Clinical Chemistry 1992; 38 (10): 2019-2024.
- (1992) Clinical Chemistry , vol.38 , Issue.10 , pp. 2019-2024
- Biliniski, H.¹

7
- 0042970632
- European Pharmacopoeia 1997 and European Pharmacopoeia 2000
- European Pharmacopoeia 1997 and European Pharmacopoeia 2000.

8
- 0029913675
- Citrate compared to low molecular weight heparin anticoagulation in chronic haemodialysis patients
- Janssen MJ et al. Citrate compared to low molecular weight heparin anticoagulation in chronic haemodialysis patients. Kidney International 1996; 49 (3): 806-813.
- (1996) Kidney International , vol.49 , Issue.3 , pp. 806-813
- Janssen, M.J.¹

9
- 0018629962
- Preventing haemorrhage in high risk haemodialysis: Regional versus low-dose heparin
- Swartz RD, Port FK. Preventing haemorrhage in high risk haemodialysis: Regional versus low-dose heparin. Kidney International 1979; 16: 513-518.
- (1979) Kidney International , vol.16 , pp. 513-518
- Swartz, R.D.¹ Port, F.K.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.